Warfarin - How Good Are we at Maintaining Target Range ?
NCT01081327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2018-12-03
Summary
Patients with atrial fibrillation are often anticoagulated with Warfarin. Warfarin has a narrow therapeutic window requiring frequent monitoring. This study aims to investigate the incidence of adverse events in the "real world" for patients receiving Warfarin for lone atrial fibrillation.
Conditions
Sponsors & Collaborators
-
NHS Tayside
collaborator OTHER_GOV -
University of Dundee
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2016-03-01
- Completion
- 2016-03-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
NCT00806624 ·Status: COMPLETED ·Phase: PHASE2
-
3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
NCT00365950 ·Status: COMPLETED ·Phase: PHASE4
-
Direct Oral Anticoagulants and Venous Thromboembolism
NCT02833987 ·Status: COMPLETED
-
Association Between Genetic Variant Scores and Warfarin Effect
NCT03894878 ·Status: COMPLETED
-
A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage
NCT03189069 ·Status: COMPLETED
-
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
NCT01305148 ·Status: SUSPENDED ·Phase: NA
-
Clarification of Optimal Anticoagulation Through Genetics
NCT00839657 ·Status: COMPLETED ·Phase: PHASE3
-
Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist
NCT00075985 ·Status: COMPLETED
-
Safer Warfarin Treatment
NCT01042067 ·Status: SUSPENDED
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
Study to Test the Accuracy of a Prototype Handheld PT/INR Device
NCT01349712 ·Status: UNKNOWN
-
Comparative Effectiveness and Safety Between Warfarin and Dabigatran
NCT03254134 ·Status: COMPLETED
-
Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants
NCT02754154 ·Status: COMPLETED
-
Early Identification of Warfarin Maintenance Dosage
NCT01178034 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Cohort Study on Warfarin Personalized Medication
NCT06428110 ·Status: COMPLETED
-
Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients
NCT02792335 ·Status: COMPLETED
-
The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage
NCT02043808 ·Status: COMPLETED
-
The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage
NCT02061748 ·Status: COMPLETED
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Study of Warfarin Maintenance Dose in Chinese Patients
NCT01855737 ·Status: UNKNOWN
-
Edoxaban and Frailty in Senior Individuals
NCT03524924 ·Status: COMPLETED
-
The Prevalence of Sub Optimal Anti Coagulation
NCT03485300 ·Status: UNKNOWN
-
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
NCT03862859 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation
NCT03666962 ·Status: UNKNOWN
-
Warfarin Anticoagulation in Patients in Sub-Saharan Africa
NCT03512080 ·Status: COMPLETED